Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last C$0.50 CAD
Change Today -0.005 / -1.00%
Volume 12.3K
APO On Other Exchanges
As of 2:50 PM 05/5/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

William S. Harris Ph.D.

Former Member of Scientific Advisory Board, Acasti Pharma Inc.
AgeTotal Calculated CompensationThis person is connected to 7 board members in 1 different organizations across 2 different industries.

See Board Relationships


Dr. William S. Harris, PhD, founded OmegaQuant Analytics, a subsidiary of Omega Biostatus, LLC in 2009 and serves as its President and Chief Executive Officer. Dr. Harris is a Research Professor of Medicine at the Sanford School of Medicine at the University of South Dakota. Dr. Harris is the principal investigator on 5 omega-3 related National Institutes of Health (NIH) grants, and the co-developer of the Omega-3 Index as a new risk factor for cardiovascular and neurocognitive ...

Read Full Background

Corporate Headquarters*

545 Promenade du Centropolis
Laval, Quebec H7T 0A3


Phone: 450-686-4555
Fax: 450-686-2505

Board Members Memberships*

There is no Board Members Memberships data available.


There is no Education data available.

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
APO:CN C$0.50 CAD -0.005


Ariel Katz Chief Executive Officer and President
Enzymotec Ltd.
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ACASTI PHARMA INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at